Showing results (231-240 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccination against influenza in New ZealandW G Scott, H M ScottPharmacoeconomics|January 8, 1996
The role of public opinion in drug resource allocation decisionsC A Melfi, B G Drake, W M TierneyPharmacoeconomics|January 8, 1996
The Prescription Drug User Fee Act of 1992. A 5-year experiment for industry and the FDAS R Shulman, K I KaitinPharmacoeconomics|January 8, 1996
Economic evaluation of an educational campaign for early diagnosis of cutaneous melanomaL Garattini, T Cainelli, G Tribbia, et al.Pharmacoeconomics|February 7, 1996
The pharmacoeconomics of ACE inhibitors in chronic heart failureJ McMurray, A DaviePharmacoeconomics|February 7, 1996
Drug use in relation to clinical activities as an instrument for prospective drug budgeting. The Belgian experienceM C Closon, R Crott, D Even-AdinPharmacoeconomics|December 9, 1995
The role of pharmacoeconomics in disease management. A pharmaceutical benefit management company perspectiveN ThomasPharmacoeconomics|May 7, 1996
Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for PharmacoeconomicsG W Torrance, D Blaker, A Detsky, et al.Pharmacoeconomics|March 9, 1994
Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostolJ D Bentkover, A M Baker, H KaplanPageof 335